The molecular basis of T cell differentiation

Immunologic Research

Volumn 19, Issue 2-3, 1999, Pages 159-168

  Flavell, Richard A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Gene regulation; Th1; Th2; Transcription factors

Indexed keywords

ARTICLE; CELL COMMUNICATION; GENE EXPRESSION REGULATION; HELPER CELL; HYBRIDIZATION; LYMPHOCYTE DIFFERENTIATION; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 0032810108     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02786484     Document Type: Article

References (56)

1. Mueller DL, Jenkins MK, Schwartz RH: Clonal expansion vs. functional clonal inactivation: a costimulatory pathway determines the outcome of T cell receptor occupancy. Annu Rev Immunol 1989;7:445-480.
2. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier L, et al.: B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993;366:76-79.
3. Freeman GJ, Borriello F, Hodes RJ, Reiser H, Gribben JG, Ng JW, et al.: Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med 1993;178:2185-2192.
4. Freeman GJ, Freedman AS, Segil JM, Lee G, Whitman JL, Nadler LM: B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol 1989;143: 2714-2722.
5. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA: Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 1991;173:721-730.
6. Linsley PS, Ledbetter JA: The role of the CD28 receptor during T cell responses. Annu Rev Immunol 1993;11:191-212.
7. Paul WE, Seder RA: Lymphocyte response and cytokines. Cell 1994; 76:241-251.
8. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H: Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 1992;257: 539-542.
9. + T cells. J Exp Med 1995;182:1591-1596.
10. Pfeiffer C, Stein J, Southwood S, Keterlaar H, Sette A, Bottomly K: Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med 1995; 181:1569-1574.
11. Kuchroo VK, Prabhu Das M, Brown JA, Ranger AM, Zamvil SS, Sobel RA, et al.: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80:707-718.
12. Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, et al.: Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 1995; 181:1145-1155.
13. Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE: Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4 producing cells. J Exp Med 1990;172:921-929.
14. Swain SL, Weinberg AD, English M, Huston G: IL-4 directs the development of Th2-like helper effectors. J Immunol 1990;145: 3796-3806.
15. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-549.
16. + T cells to enhance priming for IFNγ production and diminish IL-4 inhibition of such priming. Proc Natl Acad Sci USA 1993;90: 10,188-10,192.
17. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, et al.: IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NF-κB Immunity 1997;7:571-581.
18. + T cells. J Exp Med 1997;185:461-469.
19. Croft M, Bradley LM, Swain SL: Naive versus memory CD4 T cell response to antigen. J Immunol 1994;152:2675-2685.
20. Sprent J: Lifespans of naive, memory and effector lymphocytes. Curr Opinion Immunol 1993;5:433-438.
21. Tough DF, Sprent J: Lifespan of lymphocytes. Immunol Res 1995; 14:1-12.
22. Kaplan MH, Schindler U, Smiley ST, Grusby NJ: Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 1996;4:313-319.
23. Shimoda K, van Deursen J, Sangster MY, Srawar SR, Carson RT, Tripp RA, et al.: Lack of IL4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996;380:630-633.
24. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S-I, et al.: Essential role of Stat6 in IL-4 signaling. Nature 1996;380: 627-630.
25. Kaplan MH, Sun Y-L, Hoey T, Grusby MJ: Impaired IL-12 responses and enhanced development of Th2 cells in Stat-4 deficient mice. Nature 1996;382:174-177.
26. Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Saraward SR, Carson RT, et al.: Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 1996;382:171-174.
27. Lisitsyn N, Lisitsyn N, Wigler M: Cloning the differences between two complex genomes. Science 1993;259:946-951.
28. Hubank M, Schatz DG: Identifying differences in mRNA expression by representational difference analysis of cDNA Nucleic Acids Res 1994;22:5640-5648.
29. + T cells. Cell 1997;89:587-596.
30. Kamogawa Y, Minasi L-AE, Carding S, Bottomly K, Flavell RA: The relationship of IL-4 and IFNγ-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 1993;75:985-995.
31. Nakamura T, Kamogawa Y, Bottomly K, Flavell RA: Polarization of IL-4 and IFN-γ producing CD4+ T cells following activation of naive CD4+ T cells. J Immunol 1997;158:1085-1094.
32. Zhang DH, Cohn L, Ray P, Bottomly K, Ray A: Transcriptional factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol. Chem. 1997;272: 21597-21603.
33. Murphy E, Shibuya K, Hosken N, Openshaw P, Maino V, Davis K, et al.: Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J Exp Med 1996; 183:901-913.
34. VanDerPlocg LHT, Konings A, Oort M, Roos D, Bernini L, Flavell RA: γ-β-thalassaemia studies showing that deletion of the γ- and δ-genes influences β-globin gene expression in man. Nature 1980; 283:637-642.
35. Kioussis D, Vanin E, DeLange T, Flavell RA, Grosveld FG: β-globin gene inactivation by DNA translocation in γβ-thalassaemia. Nature 1983;306:662-666.
36. Blom van Assendelft G, Hanscombe O, Grosveld F, Greaves DR: The beta-globin dominant control region activates homologous and heterologous promoters in a tissue-specific manner. Cell 1989;56:969-977.
37. Greaves DR, Wilson FD, Lang G, Kioussis D: Human CD2 3'-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice. Cell 1989;56:979-986.
38. Ho I-C, Hodge MR, Rooney JW, Glimcher LH: The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 1996;85:973-983.
39. Ho I-C, Lo D, Glimcher LH: c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J Exp Med 1998;188:1859-1866.
40. + T cells to effector Th1 and Th2 cells. Genes Funct 1997; 1:51-68.
41. Wenner CA, Szabo SJ, Murphy KM: Identification of IL-4 promoter elements conferring Th2- restricted expression during T helper cell subset development. J Immunol 1997;158:765-773.
42. + Th2 cells but not in Th1 cells. Mol. Cell. Biol. 1997;17:1522-1534.
43. Aune TM, Flavell RA: Differential expression of transcription by a discrete NF-AT binding element from the IL-4 promoter in naive and effector CD4 T cells. J Immunol 1997;159:36-43.
44. Li B, Tournier C, Davis RJ, Flavell RA: Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation. EMBO J 1998;18:420-432.
45. Penix L, Weaver WM, Pang Y, Young HA, Wilson CB: Two essential regulatory elements in the human interferon gamma promoter confer activation specific expression in T cells. J Exp Med 1993;178:1483-1496.
46. Penix LA, Sweetser MT, Weaver WM, Hoey T, Hoeffler JP, Kerpolla TK, et al.: The proximal regulatory element of the interferon-γpromoter mediates selective expression in T cells. J Biol Chem 1996;271: 31964-31972.
47. Aune TM, Penix LA, Rincón M, Flavell RA: Memory and effector, but not naive t cells, express transcriptional activity under the control of two IFNγ promoter elements. Mol Cell Biol 1997; 17: 199-204.
48. Zhang F, Wang DZ, Boothby M, Penix LA, Flavell RA, Aune TM: Regulation of the activity of IFN-γ promoter elements during Th cell differentiation. J Immunol 1998; 161:6105-6112.
49. Rincón M, Enslen H, Raingeaud J, Recht M, Zapton T, Su MS-S, et al.: Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J 1998;17:2817-2829.
50. Dong C, Yang DD, Wysk M, Whitmarsh AJ, Davis RJ, Flavell RA: Defective T cell differentiation in the absence of JnkL Science 1998;282:2092-2095.
51. Yang D, Conze D, Whitmarsh AJ, Barrett T, Davis RJ, Rincón M, et al.: Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity 1998;9:575-585.
52. Yang DD, Kuan C-Y, Whitmarsh AJ, Rincón M, Zheng TS, Davis RJ, et al.: Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 1997;389:865-870.
53. Nakamura T, Lee RK, Nam SY, Podack ER, Bottomly K, Flavell RA: Roles of IL-4 and IFN-γ in stabilizing the T helper cell type 1 and 2 phenotype. J Immunol 1997; 158:2648-2653.
54. Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha WC, et al.: Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 1998;9: 745-755.
55. Ranger AM, Hodge MR, Gravallese EM, Oukka M, Davidson L, Alt FW, et al.: Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity 1998;8:125-134.
56. Yoshida H, Nishina H, Takimoto H, Marengere LE, Wakeham AC, Bouchard D, et al.: The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity 1998;8:115-124.